Admescope is a contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with tailor made ADME-Tox research services.
Our service offering covers research services for peptides, biologics and small molecules and is widely spread over the whole ADME-Tox area. Admescope’s expertise for biologics research lies in protein structural characterisation, LC/MS and ELISA based quantification and pharmacokinetics. We also have an active R&D program for developing more services for biologics.
We are committed to working closely with our customers through the whole study process. All the studies include comprehensive study planning, tailoring the assay according to the project’s needs and interpretation of the results with recommendations for the future. Our tailored approach enables us to provide high scientific and technical data quality that our customers can truly rely on in their decision making.
Currently Admescope serves customers in 28 countries on four continents. To learn more, please visit www.admescope.com.